International Investment Afternoon

John Livingston has served as Skyfish’s Executive Chairman since cofounding the company with Orest Pilskalns in 2014. John brings more than 30 years’ experience both leading and advising software companies. He served as CEO of www.absolute.com for 20 years and grew the company to a $1B market cap. In 2013, John began angel investing and mentoring technology startups and their founders. John is involved in Skyfish’s day-to-day operations, marketing, sales, and hiring.

Chief Executive Officer and President Dr. Bellido has over 35 years of international experience in Cybersecurity, Healthcare and Financial industries and was appointed CEO of Quantum eMotion Corp., (QNC.V) in January of 2020. He was CEO of SoundBite Medical from 2018 to 2020, and CFO from 2015 to 2018. He managed a $300M life science investment Fund (SGF-Santé) producing major winners: Cryocath, IDI-GeneOhm, Draxis, Medicago, Atrium, Axcan Pharma. His executive positions with Eli Lilly in the US and Europe included Strategic Asset Director, Global Business Unit Manager and Head of Regulatory Affairs. He was Director of the chair of Management in Bioindustry at the University of Quebec in Montreal and for 15 years has held the position of Invited Professor at the School of Management. Dr. Bellido has served as Board member and Director in more than twenty private and public companies, including at the present time Diagnos (ADK.V), Magneceuticals (USA), RegenLab (CH). He is a former member of the board of DSM Biologics Company Inc., one of the world’s leading biopharmaceutical CMOs. Dr. Bellido has an MBA, a MSc. in pharmaceutical sciences and a Ph.D. in sciences from the University of Geneva, Switzerland, and he has published over 40 original manuscripts and communications in peer reviewed scientific journals.

Jordan Trimble is the President and Chief Executive Officer as well as a Director of Skyharbour Resources Ltd. By background, he is an entrepreneur and has worked in the resource industry in various roles with numerous companies specializing in management, corporate finance and strategy, shareholder communications, business development and capital raising. Previous to Skyharbour, he was the Corporate Development Manager for Bayfield Ventures, a gold company with projects in Ontario which was successfully acquired by New Gold (TSX: NGD) in 2014. Bayfield made a high grade gold and silver discovery at its Burns Block property in the Rainy River district which is now a part of the producing Rainy River Mine. Through his career Mr. Trimble has founded and helped manage several public and private companies and has been instrumental in raising substantial amounts of capital for mining companies with his extensive network of institutional and retail investors. He is a frequent speaker at resource and mining conferences globally and has appeared on various media outlets including BNN and the Financial Post. Mr. Trimble holds a Bachelor of Science Degree with a Minor in Commerce from the University of British Columbia and he is a CFA® Charterholder currently serving as a Director of the CFA Society Vancouver.

Chief Executive Officer Dr. Helliwell is the Co-founder and CEO of Eupraxia Pharmaceuticals. A board-certified Cardiac Anesthesiologist, he previously maintained a busy quaternary clinical and academic practice with a focus on cardiac transplantation and held a double tenure as President of the Anesthesiologists of BC. Dr. Helliwell’s experience in the operating room and ICU instilled an appreciation for the value of precision drug delivery to achieve successful patient outcomes. This led him to create Eupraxia Pharmaceuticals, a company developing precision medicines in areas of high unmet medical need. In 2021, Eupraxia became the first biotech to successfully list exclusively on the Toronto Stock Exchange in almost 20 years. The company’s lead product candidate – a long-acting corticosteroid to treat osteoarthritis pain – is currently in Phase 2 clinical development. Dr. Helliwell has also applied precision delivery to the medical device space. As Co-founder and CEO of Accuro Technologies, he invented Arthrotap® – a medical device to improve the accuracy of intra-articular injections. After successfully transacting on Accuro, he moved on to serve as Chair of the Board for Guidestar Medical Devices – a company focused on precision medicines delivery for the epidural space.

President and Chairman  Vahid has been the Chief Growth officer for Victory Square technologies and has been working closely with Hydreight team and CEO for the past 18 months to help with their growth and scaling business. He has also been an advisor to FansUnite, GameOn and many other fast-growing startups. He earned a BSC in Electrical and Electronics Engineering from Simon Fraser University in 2008.

Chief Executive Officer Stuart Jara - A growth driven leader with more than 20 years’ operating experience as an executive, including CEO roles, in industrial, specialty chemicals, clean technology, and hydrogen fuel sectors. 10 years’ experience as operating partner and CEO of PE portfolio companies and startups. Held P&L responsibility for $1.2B business and involved in over $2B of capital investment and acquisitions across 12 countries. He holds an MBA from the University of Michigan Ross School of Business, and a BS in Mechanical Engineering and a BA in International Relations from Lehigh University.   Chief Financial Officer Bob Wowk has more than 30 years of global finance, strategy, and business development experience in senior finance/CFO roles with Linde, Guld Cryo (Dubai), Fluence, EnergyX, sPower/AES, Plasco and Transform Materials. Multiple successful startup company experience in the renewable sector including solar, waste to energy, lithium extraction, hydrogen. M.B.A. in finance from Wharton and a civil engineering degree from Lafayette College.